Tuesday, October 11, 2022 2:57:57 PM
https://www.coronaheadsup.com/science/variants/omicron/xbb/xbb-and-three-other-sars-cov-2-strains-found-to-be-more-antibody-evasive-than-even-bq-1-1-and-ba-2-75-2/
"The world’s first XBB wave begins in Singapore
October 8, 2022 Coronaheadsup.com Asia, Coronavirus, Evolution, Genome, Infection, Omicron, Recombinants, Research, Singapore, Testing, Transmission, XBB
The world’s first wave of the recombinant SARS-CoV-2 variant XBB has apparently begun in Singapore.
Twitter is alight with posts claiming that the recombinant SARS-CoV-2 variant XBB is creating a new wave of infections in Singapore, so we’ve taken a look at the latest information from the Singapore Ministry of Health and other reliable sources and republished it.
The new Covid wave in Singapore can be seen in the daily update slides from the Ministry of Health, shown below.
The number of new Covid cases in Singapore has risen dramatically over the past week:"
"The world’s first XBB wave begins in Singapore
October 8, 2022 Coronaheadsup.com Asia, Coronavirus, Evolution, Genome, Infection, Omicron, Recombinants, Research, Singapore, Testing, Transmission, XBB
The world’s first wave of the recombinant SARS-CoV-2 variant XBB has apparently begun in Singapore.
Twitter is alight with posts claiming that the recombinant SARS-CoV-2 variant XBB is creating a new wave of infections in Singapore, so we’ve taken a look at the latest information from the Singapore Ministry of Health and other reliable sources and republished it.
The new Covid wave in Singapore can be seen in the daily update slides from the Ministry of Health, shown below.
The number of new Covid cases in Singapore has risen dramatically over the past week:"
Recent RVVTF News
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
